Intravitrael Aflibercept Injection for The Treatment of Visual Impairment Due to Macular Oedema Secondary to Branch Retinal Vein Occlusion- Cost-Effectiveness Versus Ranibizumab
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.550
https://www.valueinhealthjournal.com/article/S1098-3015(15)02626-1/fulltext
Title :
Intravitrael Aflibercept Injection for The Treatment of Visual Impairment Due to Macular Oedema Secondary to Branch Retinal Vein Occlusion- Cost-Effectiveness Versus Ranibizumab
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02626-1&doi=10.1016/j.jval.2015.09.550
First page :
A419
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
467